BioNTech SE (BioNTech SE) FCF Yield % : 23.87 (As of Apr. 29, 2024)

View and export this data going back to 2019. Start your Free Trial

What is BioNTech SE FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, BioNTech SE's Trailing 12-Month Free Cash Flow is $5,058 Mil, and Market Cap is $21,195 Mil. Therefore, BioNTech SE's FCF Yield % for today is 23.87%.

The historical rank and industry rank for BioNTech SE's FCF Yield % or its related term are showing as below:

BNTX' s FCF Yield % Range Over the Past 10 Years
Min: -6.94 Med: 2.13 Max: 44.34
Current: 23.87

During the past 8 years, the highest FCF Yield % of BioNTech SE was 44.34%. The lowest was -6.94%. And the median was 2.13%.

BNTX's FCF Yield % is ranked better than
99.16% of 1549 companies
in the Biotechnology industry
Industry Median: -15.5 vs BNTX: 23.87

BioNTech SE's FCF Margin % for the quarter that ended in Dec. 2023 was 44.67%.

BioNTech SE FCF Yield % Historical Data

The historical data trend for BioNTech SE's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE FCF Yield % Chart

BioNTech SE Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-3.90

-0.61

1.33

38.31

20.28

BioNTech SE Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															7.94	-10.45	68.28	10.91	11.49

Competitive Comparison of BioNTech SE's FCF Yield %

For the Biotechnology subindustry, BioNTech SE's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNTech SE's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioNTech SE's FCF Yield % distribution charts can be found below:

* The bar in red indicates where BioNTech SE's FCF Yield % falls into.

BioNTech SE FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

BioNTech SE's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	5088.222	/	25089.60204
	=	20.28%

BioNTech SE's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	720.502	*	4	/	25089.60204
	=	11.49%

BioNTech SE FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

BioNTech SE FCF Yield % Related Terms

Thank you for viewing the detailed overview of BioNTech SE's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNTech SE (BioNTech SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (NAS:BNTX) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

BNTX:Mexico 0A3M:UK 22UA:Germany B1NT34:Brazil BNTX:Austria

Address

An der Goldgrube 12, Mainz, RP, DEU, D-55131

Website

https://www.biontech.de

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. COVID-19 vaccine Comirnaty is its first commercialized product.